Amphastar Pharmaceuticals (AMPH) EPS (Diluted) (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) reported EPS (Diluted) of $0.69 for Q2 2026, up 6.4% from $0.64 a year earlier and up 396.6% from the prior quarter.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) EPS (Diluted) (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Amphastar Pharmaceuticals' EPS (Diluted) came in at $1.78, down 36.5% year-over-year; for FY2025, it came in at $2.03, down 33.6% from FY2024.
- EPS (Diluted) has a five-year compound annual growth rate of 134.7% (FY2020 to FY2025).
- By year, EPS (Diluted) came in at $3.06 in FY2024 (+18.1%), $2.60 in FY2023 (+48.9%), $1.74 in FY2022 (+39.7%) and $1.25 in FY2021.
- The Q2 2026 figure ranks as the highest quarterly EPS (Diluted) since Q4 2024.
- Year over year, EPS (Diluted) gained in two of the last eight quarters, with an average decline of 25.9%.
- The high point for year-over-year EPS (Diluted) in five years was Q3 2021 (growth of 651.5%); the low point was Q1 2026 (a decline of 72.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $0.14 (Q1 2026), $0.51 (Q4 2025) and $0.36 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 4.31 |
| 10 | Amphastar Pharmaceuticals | 1.10 Bn | -43.34 Mn | 93.47 Mn | 0.69 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.69 |
| Mar 31, 2026 | 0.14 |
| Dec 31, 2025 | 0.51 |
| Sep 30, 2025 | 0.36 |
| Jun 30, 2025 | 0.64 |
| Mar 31, 2025 | 0.51 |
| Dec 31, 2024 | 0.73 |
| Sep 30, 2024 | 0.78 |
| Jun 30, 2024 | 0.73 |
| Mar 31, 2024 | 0.81 |
| Dec 31, 2023 | 0.68 |
| Sep 30, 2023 | 0.91 |
| Jun 30, 2023 | 0.49 |
| Mar 31, 2023 | 0.50 |
| Dec 31, 2022 | 0.65 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.33 |
| Mar 31, 2022 | 0.47 |
| Dec 31, 2021 | 0.40 |
| Sep 30, 2021 | 0.59 |
API Access
Amphastar Pharmaceuticals EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=AMPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();